Clinical Trial Update: CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CHP-BV followed by high-dose therapy with autologous stem cell transplant as frontline treatment for Enteropathy-associated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enteropathy-associated T-cell Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Imagine Institute | Conditions: Enteropathy Associated T-cell Lymphoma | Phase 2 | Status: COMPLETED